ADVFN US – Market Content Editor
-
Shake Shack Shares Slide After Q4 Revenue Comes in Below Expectations
Shares of Shake Shack (NYSE:SHAK) dropped about 5.5% on Monday after the burger chain reported preliminary fourth-quarter revenue that missed analyst forecasts. The company said preliminary Q4 revenue totaled $400.5 million, falling short of the consensus estimate of $409 million. For the full fiscal year 2025, Shake Shack generated total revenue of $1.45 billion, including…
-
Adaptive Biotechnologies Shares Jump After Q4 Revenue Far Outpaces Expectations
Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) surged around 16% in premarket trading on Monday after the company reported preliminary fourth-quarter revenue that came in well ahead of analyst forecasts. The commercial-stage biotechnology company said unaudited fourth-quarter revenue totaled approximately $72 million, up 51% from the same period in 2024 and significantly above the consensus estimate…
-
Birkenstock Shares Slip Even as Q1 Revenue Matches Forecasts
Shares of Birkenstock (NYSE:BIRK) declined about 2.1% on Monday after the footwear group reported preliminary first-quarter revenue that came in broadly in line with market expectations. Birkenstock said preliminary revenue for the quarter totaled €402 million, effectively matching the Bloomberg Consensus forecast of €401.8 million. The company released the early figures ahead of its appearance…
-
UnitedHealth Shares Slide After Senate Report Flags Medicare Practices
UnitedHealth Group (NYSE:UNH) shares edged about 1% lower on Monday morning after a U.S. Senate committee report concluded that the healthcare group employed aggressive methods to increase payments under the Medicare Advantage program. The investigation by the Senate Judiciary Committee, which reviewed roughly 50,000 pages of internal company documents, found that UnitedHealth had “turned risk…
-
Tempus AI Shares Jump After Company Posts Record $1.1bn Contract Backlog
Shares of Tempus AI, Inc. (NASDAQ:TEM) climbed around 12% on Monday after the precision medicine and data analytics company revealed it had reached a new milestone in total contract value, surpassing $1.1 billion as of December 31, 2025. The Chicago-based group also released preliminary, unaudited figures showing full-year 2025 data and application revenue of roughly…
-
Alaska Air Group Plans Technology Overhaul After Disruptive System Failures
Alaska Air Group Inc. (NYSE:ALK) is preparing to modernise its technology infrastructure after a series of outages disrupted operations and weighed on financial performance, as the airline works toward its ambition of becoming a global carrier. The Seattle-based airline is evaluating a shift of key operational systems, back-office processes and data center functions to cloud-based…
-
Lululemon Signals Q4 Results Likely at Top of Forecast Range
Lululemon Athletica Inc. (NASDAQ:LULU) said it now expects its fourth-quarter fiscal 2025 net revenue and diluted earnings per share to come in at the upper end of its previously issued guidance. The athleticwear group indicated that both net revenue and diluted EPS are trending toward the top of its earlier ranges of $3.500 billion to…
-
J. Jill Shares Climb After Company Lifts Q4 Guidance
J. Jill (NYSE:JILL) boosted its outlook for the fourth quarter after reporting a better-than-expected close to the holiday shopping period. The retailer’s shares jumped about 6% in premarket trading on Monday following the announcement. J. Jill now projects adjusted EBITDA for the fourth quarter in the range of $5.0 million to $6.0 million, compared with…
-
Exxon Shares Slip After Trump Says Company Is Being “Too Cute” on Venezuela
Shares in Exxon Mobil (NYSE:XOM) edged lower after U.S. President Donald Trump suggested the oil giant could be excluded from Venezuela’s energy sector, criticizing its stance on a potential return to the country. “I didn’t like Exxon’s response. You know we have so many that want it. I’d probably be inclined to keep Exxon out,”…
-
Eli Lilly Reportedly Prepares €15bn Bid for French Biotech Abivax
Eli Lilly (NYSE:LLY) is said to be working on a potential €15 billion offer to acquire French biotechnology company Abivax (NASDAQ:ABVX), according to a report published on Monday by La Lettre. The U.S. pharmaceutical group has not yet formally approached Abivax’s board, but remains interested in the transaction, the report said. Before launching an official…